NC

Narasimha Chary Satelly

Director Director DIN 02927179
DIN 02927179 First appointment Feb 2010 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Feb 2010
Shareholding value β€’β€’β€’β€’ Premium profile

About Narasimha Chary Satelly

Data last updated:

Narasimha Chary Satelly was a Director at Regina Medicorp Private Limited (2013–2018) and Director at Neocon Wallcoatings Private Limited (from 2010). The companies operate in Pharma.

DIN 02927179
Primary Designation Director
Industry Pharma
First Appointment 26 Feb 2010
Oldest Company Age 16 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Regina Medicorp Private Limited U74900TG2013PTC086531
Director26 Jun 20132013₹2.93 Cr (FY 2018)Active
Neocon Wallcoatings Private Limited U74900TG2010PTC066706
Director26 Feb 20102010Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Neocon Wallcoatings Private Limited
Regina Medicorp Private Limited
Premium access

Shareholding and investment profile for Narasimha Chary Satelly

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Narasimha Chary Satelly

Narasimha Chary Satelly was first appointed on 26 Feb 2010 as Director at Neocon Wallcoatings Private Limited. The most recent appointment on record is 26 Jun 2013 at Regina Medicorp Private Limited.

Narasimha Chary Satelly held 2 earlier board appointments: Regina Medicorp Private Limited (Director, 26 Jun 2013 to 29 Oct 2018); Neocon Wallcoatings Private Limited (Director, from 26 Feb 2010).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available